Bjorkquist Jeanette M 4
4 · ASSEMBLY BIOSCIENCES, INC. · Filed Mar 31, 2026
Research Summary
AI-generated summary of this filing
Assembly Bio (ASMB) PFO Jeanette Bjorkquist Receives RSUs, Sells Shares
What Happened Jeanette M. Bjorkquist, the company’s Principal Financial Officer and Principal Accounting Officer, received a grant of 6,500 restricted stock units (RSUs) on March 29, 2026 (no cash paid). On March 30, 2026 she disposed of 312 shares at a weighted-average price of $26.65 (proceeds ~$8,315) and 16 shares at a weighted-average price of $27.49 (proceeds ~$440), for total proceeds of about $8,755. The sales were reported as open-market dispositions.
Key Details
- Grant: 6,500 RSUs granted on 2026-03-29 (acquisition price reported $0). RSUs vest in four equal annual installments on 3/29/2027, 3/29/2028, 3/29/2029 and 3/29/2030 (F1).
- Sales: 312 shares at $26.65 (weighted avg; individual trade prices ranged $26.35–$27.26) and 16 shares at $27.49 (weighted avg; range $27.39–$27.84) on 2026-03-30 (F5, F6). Total proceeds ≈ $8,755.
- Purpose of sales: Sell-to-cover to satisfy tax withholding on RSU vesting/settlement; mandated by company administrative rule and not a discretionary sale (F4, tax withholding = F).
- Grant composition & contingency: The 6,500 RSUs represent 65% of Bjorkquist’s annual equity grant; the remaining 35% is contingent on shareholder approval to increase the plan’s authorized shares (F2).
- Administrative note: Filing corrects a prior reporting error (300 fewer shares than previously reported) (F3).
- Filing timeliness: Transaction dates 3/29–3/30/2026; Form 4 filed 3/31/2026 (appears timely).
Context
- This filing combines an equity award (RSUs) and small open-market sales used solely to cover tax obligations. Such “sell-to-cover” transactions are routine administrative actions and do not necessarily indicate intent to reduce exposure to the company. The RSUs will convert to shares only as they vest, at which point additional tax withholding or transactions could occur.
Insider Transaction Report
Form 4
Bjorkquist Jeanette M
PFO and PAO
Transactions
- Award
Common Stock
[F1][F2][F3]2026-03-29+6,500→ 11,417 total - Sale
Common Stock
[F4][F5]2026-03-30$26.65/sh−312$8,315→ 11,105 total - Sale
Common Stock
[F4][F6]2026-03-30$27.49/sh−16$440→ 11,089 total
Footnotes (6)
- [F1]Grant of restricted stock units ("RSUs"). The RSUs vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030.
- [F2]RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan") that increases the number of shares of common stock authorized for issuance under the Plan.
- [F3]Reflects 300 fewer shares than were included in Column 5 on reporting person's prior Form 4 due to an administrative error.
- [F4]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.35 to $27.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.39 to $27.84, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Signature
/s/ John O. Gunderson, as Attorney-in-Fact|2026-03-31